Patents by Inventor Magdalena Carceller Margeli

Magdalena Carceller Margeli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180258140
    Abstract: The present invention relates to targeted microcapsules comprising a skin aging compound to target fibroblast with a peptide, which is a FGF receptor agonist, wherein said peptide is coupled to the outer surface of the microcapsule. It also relates to the use of said microcapsules for the cosmetic prevention and/or cosmetic treatment of cutaneous effects of skin aging and to the cosmetic compositions comprising said microcapsules. The invention also relates to the FGF receptor agonist peptide coupled to the microcapsule.
    Type: Application
    Filed: February 24, 2016
    Publication date: September 13, 2018
    Inventors: Marisabel Mourelle Mancini, Luis Javier Cruz Ricondo, Magdalena Carceller Margeli
  • Patent number: 9745346
    Abstract: The present invention relates to a compound of formula (I) and to compositions comprising said compound, as well as the use of said compound and/or said compositions to prevent fungal and/or bacterial growth.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: August 29, 2017
    Assignee: INFINITEC ACTIVOS S.L
    Inventors: Marisabel Mourelle Mancini, Magdalena Carceller Margeli, Luis Javier Cruz Ricondo
  • Publication number: 20170081364
    Abstract: The present invention relates to a compound of formula (I) and to compositions comprising said compound, as well as the use of said compound and/or said compositions to prevent fungal and/or bacterial growth.
    Type: Application
    Filed: March 10, 2015
    Publication date: March 23, 2017
    Applicant: INFINITEC ACTIVOS S.L.
    Inventors: Marisabel Mourelle Mancini, Magdalena Carceller Margeli, Luis Javier Cruz Ricondo
  • Publication number: 20160250128
    Abstract: The present invention relates to targeted microcapsules or nanocapsules comprising a skin whitening compound to target melanocytes with a peptide, which is a MC1 receptor agonist, wherein said peptide is coupled to the outer surface of the microcapsule or nanocapsule. It also relates to the use of said microcapsules or nanocapsules for the cosmetic prevention and/or cosmetic treatment of cutaneous dark spots, and to the cosmetic compositions comprising said microcapsules or nanocapsules. The invention also relates to the MC1 receptor agonist peptide coupled to the microcapsule or nanocapsule. The invention also relates to a peptide for use as skin whitening compound.
    Type: Application
    Filed: November 20, 2014
    Publication date: September 1, 2016
    Inventors: Marisabel Mourelle Mancini, Magdalena Carceller Margeli